Immunization using ApoB-100 peptide–linked nanoparticles reduces atherosclerosis
Sign Up to like & getrecommendations! Published in 2022 at "JCI Insight"
DOI: 10.1172/jci.insight.149741
Abstract: Active immunization with the apolipoprotein B-100 (ApoB-100) peptide P210 reduces experimental atherosclerosis. To advance this immunization strategy to future clinical testing, we explored the possibility of delivering P210 as an antigen using nanoparticles, given this… read more here.
Keywords: p210 pam; immunization; 100 peptide; atherosclerosis ... See more keywords